Please login to the form below

Not currently logged in


This page shows the latest Fostair news and features for those working in and with pharma, biotech and healthcare.

PMCPA 'appalled' by Chiesi's Code of Practice breach

PMCPA 'appalled' by Chiesi's Code of Practice breach

The firm has been reprimanded by the PMCPA, which polices the UK's self-regulatory code, for making a “ misleading and unsubstantiated claim” about its asthma drug Fostair (beclometasone/formoterol). ... But over and above this, the PMCPA said there

Latest news

  • Wit and Visual Intrigue Wit and Visual Intrigue

    I scanned the latest journals to find some exceptions. Fostair – Chiesi.

  • Breathing easier

    formoterol (Fostair/Foster/Inuvair, Chiesi Farmaceutici) — this article will focus specifically on the ß2-adrenoceptor agonist and bronchodilator indacaterol.

  • Bitter sweet

    Conceived without interference. FOSTAIR— Asthma. If I were working at the agency that produced this ad, I would be really proud of the copy 'For lungfuls of life'.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Swordfish Advertising

    Archimedes Pharma. Corporate. Chiesi. Fostair. Corporate. Clenil. Atimos. Danone. Infant feeding.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...